Drugmakers Sanofi and Sumitoma Pharma America (SMPA) each announced they are partially exempting Missouri-based providers from their contract pharmacy restrictions [...] …
Category: Pharma Industry
Johnson & Johnson’s (J&J’s) proposed 340B rebate model, which has not received government approval, would give the drugmaker significantly more [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Missouri’s new law prohibiting drugmaker 340B contract pharmacy restrictions takes effect tomorrow, and the drug industry has responded with more [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Kedrion Biopharma has posted a refund notice to 340B providers, and Mylan notified covered entities of National Drug Code [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
If things were not difficult enough already for 340B providers, hospitals woke up on Friday morning to an announcement that [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal agency that oversees the 340B program did not approve drugmaker Johnson & Johnson’s (J&J’s) proposal to convert certain [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In a move that would fundamentally alter the 340B program, pharmaceutical giant Johnson & Johnson (J&J) told hospitals this morning [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
French drugmaker Sanofi has reportedly asked some hospitals for data relating to 340B purchases of a popular drug used to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, has partially exempted covered entities in Missouri [...] …